1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

How adaptive design trials can improve trial outcomes and reduce costs

SMi is hosting the 8th Adaptive Designs in Clinical Trials conference, taking place in London on the 24th and 25th March to help professionals better understand how adaptive design trials can improve trial outcomes and reduce costs.

 
 
100x100
100x100
PRLog - Mar. 5, 2014 - LONDON, U.K. -- “It’s no secret that developing a new drug or medical device is an expensive and time-consuming endeavour. However, adaptive design clinical trials can give sponsor companies the flexibility to make changes to a trial in progress without compromising the validity of its findings. This flexibility can help make trials more efficient, increase their chances of success, reduce costs and time to market, and help increase opportunities for patients participating to benefit from the treatments being studied, which could also help boost trial recruitment efforts in the long run.”

To help professionals better understand how adaptive design trials can improve trial outcomes and reduce costs, SMi is hosting the 8th Adaptive Designs in Clinical Trials conference, taking place in London on the 24th and 25th March.

This conference will bring together industry experts such as:

    Baldur Magnusson, Statistician, IIS-Translational Sciences, Novartis International AG
    Christopher Jennison, Professor of Statistics and Dean of the Faculty of Science, University of Sheffield
    Lisa Hampson, Research Associate in Medical Statistics, University Of Bristol
    Arne Ring, Head of the Statistics and Modelling Group, University Of Oxford
    Loic Darchy, Senior Statistician, Sanofi Aventis
    Michael Krams, VP - Head of Neurology Franchise, Johnson & Johnson
    Pantelis Vlachos, Principal Biostatistician, Cytel
    Frank Fleischer, Teamleader Clinical Biostatistics, Boehringer-Ingelheim
    Graeme Archer, Director, Quantitative Sciences, GlaxoSmithKline
    Jurgen Hummel, Associate Statistical Science Director, PPD
    Lilla Di Scala, Senior Statistical Scientist, Actelion Pharmaceuticals
    Mats Kvarnstrom, Principal Statistician, AstraZeneca

There are only three weeks to register for this conference so we advise to secure your place today. For more information on the programme and speakers, please visit the website http://www.smi-online.co.uk/2014adaptivedesign37.asp

Contact
Catarina Almeida
+44 (0) 20 7827 6014
***@smi-online.co.uk

Photo:
http://www.prlog.org/12291035/1

--- End ---

Click to Share

Contact Email:
***@smi-online.co.uk Email Verified
Source:SMi Group Ltd
Location:London - England - United Kingdom
Industry:Medical, Science
Tags:Adaptive Designs, drugs, medicine, science, Health
Shortcut:prlog.org/12291035
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share